Genmab | 销售成本

Cost Of Sales 更改 日
Agios Pharmaceuticals USD 627K 41K 2024-03
Almirall EUR 90.2M 15.9M 2024-03
Amarin USD 24.62M 4.97M 2024-03
Amgen USD 3.2B 88M 2024-03
AstraZeneca USD 2.22B 63M 2024-03
Bayer EUR 5.46B 977M 2024-03
BioMarin Pharmaceutical USD 125.18M 10.3M 2024-03
Demant DKK 2.98B 360M 2023-06
Exelixis USD 21.26M 2.48M 2024-03
Fresenius Medical Care EUR 3.55B 87.13M 2024-03
Galapagos EUR 2.55M 3.15M 2024-03
Genmab DKK 185M 59M 2024-03
GlaxoSmithKline GBP 1.97B 363M 2024-03
GN Store Nord DKK 2.03B 583M 2024-03
GRIFOLS EUR 1.08B 114.07M 2023-12
Hikma Pharmaceutical USD 694M 32M 2023-06
Insmed USD 17.46M 986K 2024-03
Lonza CHF 1.97B 29M 2023-06
Merck EUR 2.11B 216M 2024-03
Novartis USD 3.1B 109M 2024-03
Regeneron Pharmaceuticals USD 433.8M 83.2M 2024-03
Roche Holding CHF 7.62B 1.33B 2023-06
Sanofi EUR 3.44B 402M 2024-03
UCB EUR 802M 27M 2023-06



Genmab 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.